|
[1]
|
Evans, L., Rhodes, A., Alhazzani, W., et al. (2021) Surviving Sepsis Campaign: International Guidelines for Manage-ment of Sepsis and Septic Shock 2021. Critical Care Medicine, 49, E1063-E1143.
|
|
[2]
|
Cryan, J.F., O’Riordan, K.J., Cowan, C.S.M., et al. (2019) The Microbiota-Gut-Brain Axis. Physiological Reviews, 99, 1877-2013.
|
|
[3]
|
Deitch, E.A. (2012) Gut-Origin Sepsis: Evolution of a Concept. Surgeon, 10, 350-356. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Canfora, E.E., Meex Ruth, C.R., Venema, K., et al. (2019) Gut Microbial Metabolites in Obesity, NAFLD and T2DM. Nature Reviews Endocrinology, 15, 261-273. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Miller, T.L. and Wolin, M.J. (1996) Pathways of Acetate, Pro-pionate, and Butyrate Formation by the Human Fecal Microbial Flora. Applied and Environmental Microbiology, 62, 1589-1592. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., et al. (2016) From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites. Cell, 165, 1332-1345. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
何方, 李金星, 吴思谋. 肠源性短链脂肪酸生成机制及其饮食调控[J]. 食品科学技术学报, 2023, 41(1): 10-21.
|
|
[8]
|
Mittal, R. and Coopersmith, C.M. (2014) Redefining the Gut as the Motor of Critical Illness. Trends in Molecular Medicine, 20, 214-223. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Rekha, K., Venkidasamy, B., Samynathan, R., et al. (2022) Short-Chain Fatty Acid: An Updated Review on Signaling, Metabolism, and Therapeutic Effects. Critical Reviews in Food Science and Nutrition. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Fukuda, S., Toh, H., Hase, K., et al. (2011) Bifidobacteria Can Protect from Enteropathogenic Infection through Production of Acetate. Nature, 469, 543-547. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Chen, C.-C. and Walker, W.A. (2005) Probiotics and Prebiotics: Role in Clinical Disease States. Advances in Pediatrics, 52, 77-113. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Yap, Y.A., McLeod, K.H., McKenzie, C.I., et al. (2021) An Acetate-Yielding Diet Imprints an Immune and Anti-Microbial Programme against Enteric Infection. Clinical & Translational Immunology, 10, e1233. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Kreuzer, M. and Hardt, W.-D. (2020) How Food Affects Colonization Re-sistance against Enteropathogenic Bacteria. Annual Review of Microbiology, 74, 787-813. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Miki, T., Hoshino, Y., Sudo, N., et al. (2022) UvrY Deletion and Acetate Reduce Gut Colonization of Crohn’s Disease-Associated Adherent-Invasive Escherichia Coli by Decreasing Expression of Type 1 Fimbriae. Infection and Immunity, 90, e0066221. [Google Scholar] [CrossRef] [PubMed]
|
|
[15]
|
Burger-Van Paassen, N., Vincent, A., Puiman, P.J., et al. (2009) The Regulation of Intestinal Mucin MUC2 Expression by Short-Chain Fatty Acids: Implications for Epithelial Protection. Biochemical Journal, 420, 211-219. [Google Scholar] [CrossRef]
|
|
[16]
|
Thorburn, A.N., Macia, L. and Mackay, C.R. (2014) Diet, Metabolites, and “Western-Lifestyle” Inflammatory Diseases. Immunity, 40, 833-842. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Jirsova, Z., Heczkova, M., Dankova, H., et al. (2019) The Ef-fect of Butyrate-Supplemented Parenteral Nutrition on Intestinal Defence Mechanisms and the Parenteral Nutri-tion-Induced Shift in the Gut Microbiota in the Rat Model. BioMed Research International, 2019, Article ID: 7084734. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Nastasi, C., Fredholm, S., Willerslev-Olsen, A., et al. (2017) Butyrate and Propionate Inhibit Antigen-Specific CD8 T Cell Activation by Suppressing IL-12 Production by Antigen-Presenting Cells. Scientific Reports, 7, Article No. 14516. [Google Scholar] [CrossRef] [PubMed]
|
|
[19]
|
Park, J., Kim, M., Kang, S.G., et al. (2015) Short-Chain Fatty Acids Induce both Effector and Regulatory T Cells by Suppression of Histone Deacetylases and Regulation of the MTOR-S6K Pathway. Mucosal Immunology, 8, 80-93. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Lou, X.R., Xue, J.F., Shao, R.F., et al. (2022) Fecal Microbiota Trans-plantation and Short-Chain Fatty Acids Reduce Sepsis Mortality by Remodeling Antibiotic-Induced Gut Microbiota Disturbances. Frontiers in Immunology, 13, Article ID: 1063543. [Google Scholar] [CrossRef] [PubMed]
|
|
[21]
|
Yin, Y.H., Sichler, A., Ecker, J., et al. (2023) Gut Microbiota Promote Liver Regeneration through Hepatic Membrane Phospholipid Biosynthesis. Journal of Hepatology, 78, 820-835. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Behary, J., Amorim, N., Jiang, X.-T., et al. (2021) Gut Microbiota Impact on the Peripheral Immune Response in Non-Alcoholic Fatty Liver Disease Related Hepatocellular Carcinoma. Nature Communications, 12, Article No. 187. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
Van Den Berg Fons, F., Van Dalen, D., Hyoju, S.K., et al. (2021) Western-Type Diet Influences Mortality from Necrotising Pancreatitis and Demonstrates a Central Role for Butyrate. Gut, 70, 915-927. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Sun, J., Furio, L., Mecheri, R., et al. (2015) Pancreatic β-Cells Limit Autoimmune Diabetes via an Immunoregulatory Antimicrobial Peptide Expressed under the Influence of the Gut Microbiota. Immunity, 43, 304-317. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Murashige, D., Jang, C., Neinast, M., et al. (2020) Compre-hensive Quantification of Fuel Use by the Failing and Nonfailing Human Heart. Science, 370, 364-368. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Tang, T.W.H., Chen, H.-C., Chen, C.-Y., et al. (2019) Loss of Gut Microbiota Alters Immune System Composition and Cripples Postinfarction Cardiac Repair. Circulation, 139, 647-659. [Google Scholar] [CrossRef]
|
|
[27]
|
Jia, Q.J., Li, H., Zhou, H., et al. (2019) Role and Effective Therapeutic Target of Gut Microbiota in Heart Failure. Cardiovascular Therapeutics, 2019, Article ID: 5164298. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Deng, F., Zhang, L.-Q., Wu, H., et al. (2022) Propionate Alleviates Myocardial Ischemia-Reperfusion Injury Aggravated by Angiotensin II Dependent on Caveolin-1/ACE2 Axis through GPR41. International Journal of Biological Sciences, 18, 858-872. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Gavelli, F., Castello, L.M. and Avanzi, G.C. (2021) Management of Sepsis and Septic Shock in the Emergency Department. Internal and Emergency Medicine, 16, 1649-1661. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Wu, T., Xu, F.M., Su, C., et al. (2020) Alterations in the Gut Microbiome and Cecal Metabolome during Klebsiella pneumoniae-Induced Pneumosepsis. Frontiers in Immunology, 11, Article No. 1331. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Trompette, A., Gollwitzer, E.S., Yadava, K., et al. (2014) Gut Microbiota Metabolism of Dietary Fiber Influences Allergic Airway Disease and Hematopoiesis. Nature Medicine, 20, 159-166. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Fontecha-Barriuso, M., Martin-Sanchez, D., Martinez-Moreno, J.M., et al. (2020) The Role of PGC-1α and Mitochondrial Biogenesis in Kidney Diseases. Biomolecules, 10, Article No. 347. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Pirozzi, C., Francisco, V., Guida, F.D., et al. (2018) Butyrate Modulates Inflammation in Chondrocytes via GPR43 Receptor. Cellular Physiology and Biochemistry, 51, 228-243. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Li, M., Van Esch Betty, C.A.M., Henricks, P.A.J., et al. (2018) The An-ti-Inflammatory Effects of Short Chain Fatty Acids on Lipopolysaccharide- or Tumor Necrosis Factor α-Stimulated Endothelial Cells via Activation of GPR41/43 and Inhibition of HDACs. Frontiers in Pharmacology, 9, Article No. 533. [Google Scholar] [CrossRef] [PubMed]
|